Joseph Walland - Alphatec Holdings Senior Solutions
| ATEC Stock | USD 10.37 0.76 7.91% |
Executive
Joseph Walland is Senior Solutions of Alphatec Holdings
| Age | 45 |
| Address | 1950 Camino Vida Roble, Carlsbad, CA, United States, 92008 |
| Phone | 760 431 9286 |
| Web | https://www.atecspine.com |
Alphatec Holdings Management Efficiency
The company has return on total asset (ROA) of (0.121) % which means that it has lost $0.121 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (211.3714) %, meaning that it created substantial loss on money invested by shareholders. Alphatec Holdings' management efficiency ratios could be used to measure how well Alphatec Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of November 29, 2024, Return On Tangible Assets is expected to decline to -0.31. In addition to that, Return On Capital Employed is expected to decline to -0.28. At present, Alphatec Holdings' Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 371.8 M, whereas Other Assets are forecasted to decline to 0.95.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Shana Zink | Treace Medical Concepts | N/A | |
| Rosalyn dIncelli | Establishment Labs Holdings | N/A | |
| Roberto Donadello | Orthofix Medical | N/A | |
| Scot Elder | Treace Medical Concepts | 49 | |
| Jeremy JD | Sight Sciences | 54 | |
| Todd Puckett | Axogen Inc | N/A | |
| Rebecca Williston | Rxsight | N/A | |
| Trui Hebbelinck | LivaNova PLC | 52 | |
| Michael JD | Si Bone | 46 | |
| Jrme Erath | Pulmonx Corp | N/A | |
| Jill Mason | Orthofix Medical | N/A | |
| Suzanne Armstrong | Orthofix Medical | N/A | |
| Bryan Olin | LivaNova PLC | 57 | |
| Brent Lalomia | CONMED | 49 | |
| Alex CMA | LivaNova PLC | 54 | |
| Anthony Recupero | Si Bone | 65 | |
| Sarah Huber | Pulmonx Corp | N/A | |
| Deanna Wilke | LivaNova PLC | N/A | |
| Aaron Berutti | Treace Medical Concepts | 45 | |
| Matthew Millard | Paragon 28 | N/A | |
| Stephanie Walsh | Orthofix Medical | N/A | |
Management Performance
| Return On Equity | -211.37 | ||||
| Return On Asset | -0.12 |
Alphatec Holdings Leadership Team
Elected by the shareholders, the Alphatec Holdings' board of directors comprises two types of representatives: Alphatec Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alphatec. The board's role is to monitor Alphatec Holdings' management team and ensure that shareholders' interests are well served. Alphatec Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alphatec Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Patrick Miles, Chairman of the Board | ||
| Scott Lish, Vice President - Development | ||
| Brian Snider, Executive Vice President - Strategic Marketing and Product Development | ||
| Ali Shorooghi, Senior Marketing | ||
| Eric Dasso, Executive Technologies | ||
| Joseph Walland, Senior Solutions | ||
| Tyson Marshall, General Secretary | ||
| David Sponsel, Executive Vice President - Sales | ||
| Kelli Howell, Executive Vice President - Clinical Strategies | ||
| Luiz Pimenta, Chief Medical Officer | ||
| Craig Hunsaker, Executive Vice President - People and Culture | ||
| Todd Koning, Executive CFO | ||
| Jonathan Allen, Executive Vice President - Commercial Operations |
Alphatec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alphatec Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -211.37 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 1.95 B | ||||
| Shares Outstanding | 141.77 M | ||||
| Shares Owned By Insiders | 25.48 % | ||||
| Shares Owned By Institutions | 57.92 % | ||||
| Number Of Shares Shorted | 10.59 M | ||||
| Price To Earning | (2.14) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Alphatec Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alphatec Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alphatec Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alphatec Holdings Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alphatec Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Alphatec Stock refer to our How to Trade Alphatec Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alphatec Holdings. If investors know Alphatec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alphatec Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share 4.083 | Quarterly Revenue Growth 0.274 | Return On Assets (0.12) | Return On Equity (211.37) |
The market value of Alphatec Holdings is measured differently than its book value, which is the value of Alphatec that is recorded on the company's balance sheet. Investors also form their own opinion of Alphatec Holdings' value that differs from its market value or its book value, called intrinsic value, which is Alphatec Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alphatec Holdings' market value can be influenced by many factors that don't directly affect Alphatec Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alphatec Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alphatec Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alphatec Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.